New Market Report Now Available: Influenza VLP Vaccine (Seasonal Influenza Vaccines) Forecast and Market Analysis
GlobalData has released its new PharmaPoint Drug Evaluation report, "Influenza VLP Vaccine (Seasonal Influenza Vaccines) Forecast and Market Analysis". Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently, trivalent intramuscular vaccines such as Sanofi's Fluzone and Vaxigrip, GlaxoSmithKline's Fluarix and FluLaval and Novartis' Fluvirin garner the majority stake of the...
View full press release